THURSDAY, Sept. 28, 2023 (HealthDay News) – An advisory panel to the U.S. Food and Drug Administration on Wednesday voted resoundingly against recommending a stem cell-based experimental treatment for ALS. Although the FDA isn’t bound by the votes of its advisory panels, agency scientists have already penned a scathing reviewContinue Reading

THURSDAY, Sept. 14, 2023 (HealthDay News) — Many Medicare patients can’t get help close to home for brain and nervous system issues. Nearly 1 in 5 Medicare recipients in the United States live at least 50 miles from their neurologist. “Our study found a substantial travel burden exists for someContinue Reading